Gentiva: Staying a Step Ahead of HOPE Compliance
How Gentiva’s Chief Medical Officer leveraged Intelligence Group Advisor insight to prepare for a critical industry change.
The Problem
As a leading provider of hospice and palliative care, it’s imperative that Gentiva stay abreast of regulatory changes with the potential to impact care delivery. One of the most significant developments on the horizon: HOPE, the new CMS-mandated hospice assessment tool. Gentiva’s Chief Medical Officer knew that proper planning for new requirements were essential.
The Goal
Gentiva’s objective was to be fully informed, prepared, and aligned around the requirements for HOPE implementation. The CMO needed a fast, focused path forward that would go beyond bullet points and offer meaningful context.
The Approach
The Intelligence Group stepped in with a simple, high-value solution: a personalized one-on-one session between the Gentiva CMO and a compliance-focused IG Advisor.
The advisor prepared a comprehensive recap – key points and questions raised, as well as anonymized peer commentary that gave deeper context to the discussion. These direct quotes provided real-world framing that helped translate abstract policy change into tangible operational challenges and opportunities.
The session also created space for the CMO to pose questions, consider implications, and understand how other organizations were approaching the shift.
The Results
The CMO came away with a clearer understanding of HOPE’s impact and a firmer grasp on how to guide Gentiva’s internal compliance readiness process. Moreover, they gained access to peer-informed strategies and concerns, giving the Gentiva team a broader, more nuanced perspective on what HOPE readiness really looks like. Their strategic reset included:
- Confidence in the ability to anticipate and meet evolving compliance requirements
- Validation, feedback and advice from fellow leaders already in the HOPE planning stages
- A systematic framework for faster, more informed internal decision-making